The histone deacetylase inhibitor M344 as a multifaceted therapy for pancreatic cancer

por Knoche, Shelby M., Brumfield, Gabrielle L., Goetz, Benjamin T., Sliker, Bailee H., Larson, Alaina C., Olson, Madeline T., Poelaert, Brittany J., Bavari, Audrey, Yan, Ying, Black, Jennifer D., Solheim, Joyce C.
Publicado 2022

Amyloid Precursor-like Protein 2 Expression Increases during Pancreatic Cancer Development and Shortens the Survival of a Spontaneous Mouse Model of Pancreatic Cancer

por Poelaert, Brittany J., Knoche, Shelby M., Larson, Alaina C., Pandey, Poomy, Seshacharyulu, Parthasarathy, Khan, Nuzhat, Maurer, H. Carlo, Olive, Kenneth P., Sheinin, Yuri, Ahmad, Rizwan, Singh, Amar B., Batra, Surinder K., Rachagani, Satyanarayana, Solheim, Joyce C.
Publicado 2021